BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1073 related articles for article (PubMed ID: 19530157)

  • 1. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?
    Merli GJ
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S27-34. PubMed ID: 19530157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.
    Petersen LJ
    Cancer Treat Rev; 2009 Dec; 35(8):754-64. PubMed ID: 19762155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.
    Farge D; Durant C; Villiers S; Long A; Mahr A; Marty M; Debourdeau P;
    Thromb Res; 2010 Apr; 125 Suppl 2():S108-16. PubMed ID: 20433988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of deep vein thrombosis in cancer patients.
    Lee AY
    Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep vein thrombosis prophylaxis: friend or foe.
    Rahman S
    Am J Ther; 2009; 16(4):300-3. PubMed ID: 19092638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
    Romera-Villegas A; Cairols-Castellote MA; Vila-Coll R; Martí-Mestre X; Colomé E; Iguaz I
    Ann Vasc Surg; 2010 Jul; 24(5):628-39. PubMed ID: 19932949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis and treatment of venous thromboembolism in cancer patients: a review.
    Ansell JE
    Am J Clin Oncol; 2009 Aug; 32(4 Suppl):S8-S12. PubMed ID: 19654482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
    Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of venous thromboembolism during pregnancy.
    Weitz JI
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S22-6. PubMed ID: 19213066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unanswered questions in venous thromboembolism.
    Weitz JI
    Thromb Res; 2009; 123 Suppl 4():S2-S10. PubMed ID: 19303498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of deep venous thrombosis.
    Ortel TL
    Vascular; 2008; 16 Suppl 1():S64-70. PubMed ID: 18544309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of thrombosis in cancer: primary prevention and secondary prophylaxis.
    Lee AY
    Br J Haematol; 2005 Feb; 128(3):291-302. PubMed ID: 15667530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism in pregnancy.
    James AH
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):326-31. PubMed ID: 19228606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
    Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
    Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 8(th) American College of Chest Physicians Guidelines - a perspective on venous thromboembolism guidelines.
    Squizzato A; Ageno W
    Thromb Haemost; 2009 Jan; 101(1):31-5. PubMed ID: 19132186
    [No Abstract]   [Full Text] [Related]  

  • 17. Should we follow the 9th ACCP guidelines for VTE prevention in surgical patients?
    Arcelus JI; Villar JM; Muñoz N
    Thromb Res; 2012 Oct; 130 Suppl 1():S4-6. PubMed ID: 23026658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antithrombotic drugs: potential for use in oncology.
    Levine MN
    J Clin Oncol; 2009 Oct; 27(29):4912-8. PubMed ID: 19738103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge of venous thromboembolism (VTE) prevention among hospitalized patients.
    Le Sage S; McGee M; Emed JD
    J Vasc Nurs; 2008 Dec; 26(4):109-17. PubMed ID: 19022169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.